1. Pharmacokinetics and Safety of Valaciclovir in Children with Epstein-Barr Virus Illness

   • Michael W. Simon
   • Douglas N. Fish
   • Robert G. Deeter

   Original Research Article 27 November 2012 Pages: 365 - 373

   

2. Six-Month Toxicity Study of Oral Administration of D-003 in Sprague Dawley Rats

   • Rafael Gámez
   • Rosa Más
   • Eddy Goicochea

   Original Research Article 27 November 2012 Pages: 375 - 386

   

3. Users’ Perspectives on Bleeding Patterns after Two Years of Levonorgestrel-Releasing Intrauterine System Use

   • Roberta Nascimento
   • Luis Bahamondes
   • Carlos Alberto Petta

   Short Communication 27 November 2012 Pages: 387 - 391

   

4. Levonorgestrel — Gedeon Richter

   Adis R&D Profile 27 November 2012 Pages: 392 - 394

   

5. Levonorgestrel — Leiras Oy

   Adis R&D Profile 27 November 2012 Pages: 395 - 397

   

6. Levonorgestrel — Implant

   Adis R&D Profile 27 November 2012 Pages: 398 - 400

   

7. Profile Summary

   Adis Profile 27 November 2012 Pages: 401 - 401

   

8. Bismuth Subcitrate/Metronidazole/Tetracycline — Axcan Pharma

   Adis R&D Profile 27 November 2012 Pages: 402 - 404

   

9. Blonanserin

   Adis R&D Profile 27 November 2012 Pages: 405 - 406

   

10. Ciclesonide

    Adis R&D Profile 27 November 2012 Pages: 407 - 410

    

11. HIV Vaccine — Immune Response

    Adis R&D Profile 27 November 2012 Pages: 411 - 420

    

12. Melagatran

    Adis R&D Profile 27 November 2012 Pages: 421 - 425

    

13. Prulifloxacin

    Adis R&D Profile 27 November 2012 Pages: 426 - 430

    

14. Ximelagatran

    Adis R&D Profile 27 November 2012 Pages: 431 - 434